Postdoctoral Researcher - Multi-Omics & Drug Discovery | Biologe (m/w/d)

Unknown Employer

Köln, Nordrhein-Westfalen, Deutschland
Published Nov 23, 2025
Full-time
No information

Job Summary

This Postdoctoral Researcher role in Multi-Omics & Drug Discovery at the University Hospital of Cologne offers a unique opportunity to contribute to cutting-edge translational research focused on innovative therapies for serious bacterial infections. The core responsibility involves implementing and optimizing robotics-based, high-throughput screening pipelines for antibiotic drug discovery, specifically studying the evolutionary dynamics of antibiotic resistance within the DFG-funded Collaborative Research Centre 1310. Day-to-day tasks include coordinating automated liquid handling workflows, performing strain engineering (barcoding/recombineering), and integrating complex multi-omics datasets (transcriptomic, proteomic, phenotypic) for predictive modeling. Candidates must hold a PhD in Microbiology, Biotechnology, or a related field, possess experience with automation/robotics platforms, and demonstrate excellent English communication skills. This position provides a secure, challenging environment with access to state-of-the-art BSL2/BSL3 facilities and strong national/international collaboration networks, aimed at high-impact scientific publication.

Required Skills

Education

PhD in Microbiology, Biotechnology, Systems Biology or related field

Experience

  • Professional experience in high-throughput screening, automation or robotics platforms
  • Knowledge of data handling, scripting (R / Python), or bioinformatics pipelines is desirable
  • Experience in BSL2 / BSL3 laboratory work (beneficial, specifically with Mycobacterium tuberculosis)

Languages

English (Fluent)

Additional

  • Full-time position (38.5 h/week); Limited for 3 years according to WissZeitVG (German Fixed-Term Employment Contracts in Academia Act); Salary based on TV-L (Collective Agreement for the Public Service of the Federal States); Start date February 1, 2026.